Nuvalent, Inc. Company Profile, Contacts & Intelligence
Nuvalent, Inc. Overview
Nuvalent is creating precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in structure-based design, Nuvalent develops innovative small molecules with exquisite target selectivity to overcome resistance, minimize adverse events, and drive more durable responses. Nuvalent is advancing a robust pipeline with parallel lead programs in ROS1-positive and ALK-positive NSCLC, along with multiple discovery-stage research programs. To learn more, visit www.nuvalent.com.
- Headquarters
- Cambridge, Massachusetts, United States
- Website
- www.nuvalent.com
- Industry
- Biotechnology Research
- Founded
- 2017
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology)
Nuvalent, Inc. Contact Intelligence
See which contact channels and departments are represented in the visible AeroLeads data.
Nuvalent, Inc. People & Org Chart Preview
Sample people records show job titles and whether email or phone data is available without exposing raw contact details.
Compare Similar Companies to Nuvalent, Inc.
Explore companies in related markets and compare their industry and employee estimates.
| Company | Industry / match | Employee estimate | Page |
|---|---|---|---|
| Tessera Therapeutics | Biotechnology Research | 326 | View company |
| KalVista Pharmaceuticals, Inc. | Biotechnology Research | 259 | View company |
| Dyno Therapeutics | Biotechnology Research | 108 | View company |
| Rapport Therapeutics | Biotechnology Research | 82 | View company |
| Bicara Therapeutics | Biotechnology Research | 73 | View company |
| GC Therapeutics | Biotechnology Research | 43 | View company |
| Quiver Bioscience | Biotechnology Research | 39 | View company |
| Fable Therapeutics | Biotechnology Research | 33 | View company |
| Delphia Therapeutics | Biotechnology Research | 29 | View company |
| Myrobalan Therapeutics | Biotechnology Research | 16 | View company |